Knee strengthening exercises for boys with hemophilia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests whether special knee-strengthening exercises using a machine can improve how well boys with hemophilia can use their affected knee. The goal is to see if these exercises help with daily activities and reduce joint problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have moderate hemophilia.
- The bleeding or pain is in one knee only, and it's mild to moderate.
- Your child can walk and stand without help.
- No other health issues like seizures or problems with movement.
- Your child is not having any active joint or muscle bleeding during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how well children with hemophilia use their arms and hands compared to healthy children. If your child has hemophilia A or B, is on regular treatment, and has no inhibitors or recent bleeds in the arm, they may be able to join.
This study looks at what helps or limits physical activity in adults with hemophilia who have joint damage in their legs. It may help doctors find better ways to support patients in staying active.
This trial tests whether a special type of exercise that limits blood flow is safe and possible for people with hemophilia. It might help strengthen muscles without causing joint bleeds.
This study checks if two simple walking and balance tests are reliable for people with hemophilia who have had joint bleeds. It may help doctors better track joint health and function.
This study uses MRI scans to look at the knee joints of adults with hemophilia who have had repeated knee bleeds. It aims to understand how the joint is affected, which could help guide better care.
This study uses ultrasound to check if joints that are currently healthy stay healthy in people with hemophilia A who are taking emicizumab (Hemlibra) as their regular treatment. It aims to see if this treatment helps prevent joint damage over time.
Hear when a new Hemophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.